Adding ribavirin to interferon alpha-2b for chronic hepatitis C infection increased virological response and nausea
January 1998
Article
| Related Files |
|---|
View PDF Version
(9824337.pdf, 0.1MB) |
Keywords
- Humans
- Treatment Outcome
- Drug Therapy, Combination
- Double-Blind Method
- Randomized Controlled Trials
- Antiviral Agents/*therapeutic use
- Hepatitis C, Chronic/*drug therapy
- Interferon Alfa-2b/*therapeutic use
- Ribavirin/*therapeutic use
- Nausea/etiology
Automatically Extracted Terms
- patient
- combination therapy
- interferon
- combination
- therapy
- interferon -2 b
- hepatitis
- treatment
- hepatitis c
- ribavirin
- monotherapy
- response
- outcome
- 24 weeks
- virological
- interferon monotherapy
- infection
- hepatitis c infection
- hcv rna
- trial
